Figure 3.
Induced degradation of Hsp90 client proteins via 3g (top), 12 (middle), or 13a (bottom) inhibition of Hsp90. Compound, at varying concentrations, (μM) was evaluated for its ability to downregulate several client proteins as described in the Experimental Section. GA (500 nM) and DMSO were used as positive and negative controls, respectively.